Opportunity Information: Apply for RFA CA 23 033
This NIH funding opportunity (RFA-CA-23-033) supports implementation science projects focused on improving cancer control for people living with HIV (PLWH) in low- and middle-income countries (LMICs). The central idea is to speed up the real-world integration of evidence-based cancer prevention, screening, diagnosis, and treatment approaches for PLWH by building on HIV service delivery platforms that already exist in many LMICs. Rather than funding basic discovery research, the emphasis is on practical, on-the-ground work that explains why proven cancer control interventions are not reaching PLWH consistently, and then designs and tests strategies to overcome those barriers in ways that can last over time.
The FOA is specifically looking for applications that identify, understand, and address obstacles to adoption, integration, and sustainability of cancer control interventions for PLWH in LMIC settings. That includes examining the factors that block implementation at multiple levels: patient and community factors (for example, stigma, transportation costs, trust, competing needs), clinic and provider factors (training gaps, workflow constraints, shortages of oncology services, limited diagnostic capacity), and broader health system and policy factors (financing, referral networks, supply chains, data systems, and national guidelines). A key expectation is that applicants will generate implementation-relevant data directly in LMIC contexts, so the findings are grounded in local realities and can inform equitable cancer control approaches not only in the study country but also in other settings worldwide.
Projects are expected to rely on multidisciplinary teams, bringing together expertise in HIV, cancer, and implementation science. The work should be tailored to the cancer control needs of PLWH in the specific LMIC context proposed. In practice, that means applicants should choose cancer control targets that make sense epidemiologically and programmatically for the country or region they are working in, and then develop implementation strategies that fit the local HIV care infrastructure. The opportunity is structured to encourage leveraging HIV treatment and prevention platforms, such as HIV clinics, community outreach, ART distribution systems, and existing monitoring and evaluation structures, as a backbone for delivering cancer-related services more consistently.
The award mechanism is a U01 cooperative agreement, which generally means NIH anticipates substantial scientific involvement during the project (for instance, collaborative planning, milestones, and ongoing coordination between the funded team and NIH program staff). The FOA notes that clinical trials are optional, so applicants may propose studies that include or do not include clinical trial components, depending on the research questions. The funding instrument category is discretionary, and the activity areas are education and health, with CFDA numbers 93.394, 93.395, and 93.399.
Eligibility is broad and includes many types of U.S. and non-U.S. organizations. In addition to typical government and academic applicants (state, county, city or township governments; special districts; independent school districts; public and state-controlled and private institutions of higher education), eligible applicants include federally recognized tribal governments and other tribal organizations, public housing authorities/Indian housing authorities, nonprofits with or without 501(c)(3) status, for-profit organizations (other than small businesses) and small businesses. The FOA also explicitly highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities, faith-based or community-based organizations, non-domestic (non-U.S.) entities/foreign organizations, regional organizations, and U.S. territories or possessions. This wide eligibility reflects an interest in supporting partnerships that can credibly operate in LMIC environments and connect research with real service delivery systems.
Key administrative details included in the source information are that the sponsoring agency is the National Institutes of Health, the original closing date listed was 2023-12-15, and the award ceiling shown is $500,000. The funding opportunity was created on 2023-04-06. While the number of expected awards is not specified in the provided text, the overall framing indicates a competitive research funding opportunity aimed at producing actionable implementation evidence and scalable strategies to improve cancer outcomes among PLWH by embedding cancer control into HIV programs in LMICs.Apply for RFA CA 23 033
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394, 93.395, 93.399.
- This funding opportunity was created on 2023-04-06.
- Applicants must submit their applications by 2023-12-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Cooperative Agreement for CESU-affiliated Partner with Gulf Coast Cooperative Ecosystem Studies Unit
Previous opportunity: FY23 IIJA Bureau of Land Management Eastern States (ES) Aquatic Resource Management
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 23 033
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 23 033) also looked into and applied for these:
| Funding Opportunity |
|---|
| Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 001 Funding Number: RFA DE 24 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) Apply for PAR 23 158 Funding Number: PAR 23 158 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 23 157 Funding Number: PAR 23 157 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Apply for PAR 23 155 Funding Number: PAR 23 155 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed) Apply for RFA DA 24 020 Funding Number: RFA DA 24 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 24 038 Funding Number: RFA DA 24 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 24 021 Funding Number: RFA DA 24 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) Apply for PAR 23 170 Funding Number: PAR 23 170 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional) Apply for RFA DA 24 022 Funding Number: RFA DA 24 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required) Apply for RFA DA 24 015 Funding Number: RFA DA 24 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional) Apply for RFA DA 24 023 Funding Number: RFA DA 24 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA CA 23 029 Funding Number: RFA CA 23 029 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 24 005 Funding Number: RFA CA 24 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 23 034 Funding Number: RFA CA 23 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 23 035 Funding Number: RFA CA 23 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed) Apply for RFA CA 23 038 Funding Number: RFA CA 23 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed) Apply for RFA DA 24 019 Funding Number: RFA DA 24 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional) Apply for RFA DA 24 016 Funding Number: RFA DA 24 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed) Apply for RFA DA 24 028 Funding Number: RFA DA 24 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) Apply for RFA DA 24 024 Funding Number: RFA DA 24 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 23 033", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
